HealWELL AI, Inc. is a health care technology company, which focuses on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. The company is headquartered in Toronto, Ontario and currently employs 350 full-time employees. The company went IPO on 2007-04-25. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The firm's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere and Mutuo subsidiaries. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.
Dr. Alexander Dobranowski est le Chief Executive Officer de Healwell AI Inc., il a rejoint l'entreprise depuis 2020.
Quelle est la performance du prix de l'action HealWELL AI Inc. ?
Le prix actuel de HealWELL AI Inc. est de $0.62, il a augmenté de 2.99% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Healwell AI Inc. ?
Healwell AI Inc. appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Healwell AI Inc. ?
La capitalisation boursière actuelle de Healwell AI Inc. est de $172.6M
Est-ce que Healwell AI Inc. est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 14 analystes ont établi des notations d'analystes pour Healwell AI Inc., y compris 4 achat fort, 12 achat, 1 maintien, 0 vente et 4 vente forte